Science 37 has raised $31m in Series B financing to support its end-to-end decentralized clinical trial services and technology platform.
The US Food and Drug Administration (FDA) has signed an agreement with CluePoints to "further explore" a data-driven approach to quality oversight in clinical trials.
Validic and Sutter Health are collaborating on a federal pilot project that seeks to determine how patient-generated health data can be best delivered to researchers.
Lovelace Biomedical launched this week as a not-for-profit preclinical contract research organization (CRO) with a business model that will let it “put science first.”
Almac Group’s Diagnostics business will engage with pharma to validate the link between its immune response assay and checkpoint inhibitor based therapy.
Content Provided by Reading Scientific Services Ltd.
Oral dosage forms remain one of the most flexible and effective treatments available to patients. Dissolution testing is a requirement for all solid oral dosage forms and is used throughout the development life-cycle for product release and stability testing. It is a pivotal analytical test used for detecting physical changes in an active pharmaceutical ingredient and formulated product